Erythropoietin resistance is a manifestation of the SVRR to prevent complications of hyperviscosity, such as hypertension and thrombosis. In addition, the SVRR causes decreased transcription of the erythropoietin gene. This evidence concerns the gene EPO and hypertensive disorder.